An atlas of genetic influences on human blood metabolites

Shin et al., Nature Genetics, 2014 [ Article | SI Text ]

Locus 73: CRAT (9q34.11)

Meta-analysis summary statistics for associations meeting genome-wide significance
Lead SNPBiochemicalsEA/OANtotalEAFEffect (SE)PmetaDetails
rs7849270 C-glycosyltryptophan* / succinylcarnitine A/G 6530 0.3 0.025 (0.003) 2.82·10-21 show
rs10988217 succinylcarnitine A/G 6552 0.39 -0.016 (0.002) 1.36·10-18 show

EA = effect allele; OA = other allele; EAF = frequency of effect allele;

Summary of biological annotations
SNPrs10988217
Chromosomal locationChr9: 130,914,462 (9q34.11)
Gene (distance)CRAT (15,047)
Predicted causal geneCRAT
Gene/protein classification-
Metabolite (Pathway)C-glycosyltryptophan* (Tryptophan metabolism; Amino acid)
succinylcarnitine (Krebs cycle; Energy)
Biochemical locus-metabolite relationshipCRAT encodes carnitine O-acetyltransferase, which catalyzes the interconversion of short chain acylcarnitines and acyl-coenzyme A derivatives. CRAT has maximal activity for propionyl-CoA [2351134]. Ratio interpretation: n/a.
eQTL associationsCRAT (L), ENDOG (L), IER5L (L), PPP2R4 (F), PPP2R4 (S) †

† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;

Medical information
Complex trait associations-
Known metabolite associations-
Inborn error of metabolism-

Pharmacological information
ChEMBL IDCHEMBL3184
Drug information Compounds with no inhibitory activity in ChEMBL

Locus information for top associated metabolite

HapMap2 imputation

Imputation HapMap

1KGP imputation

Imputation 1KGP

 

Network view
Association map